AK104 in Neoadjuvant Treatment of Cervical Cancer

NCT05227651 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
14
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Akeso